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Introduction: The disability-adjusted life year (DALY) is widely used to assess the burden of different health problems
and risk factors. The disability weight, a value anchored between 0 (perfect health) and 1 (equivalent to death), is
necessary to estimate the disability component (years lived with disability, YLDs) of the DALY. After publication of the
ground-breaking Global Burden of Disease (GBD) 1996, alternative sets of disability weights have been developed over
the past 16 years, each using different approaches with regards to the panel, health state description, and valuation
methods. The objective of this study was to review all studies that developed disability weights and to critically assess
the methodological design choices (health state and time description, panel composition, and valuation method).
Furthermore, disability weights of eight specific conditions were compared.
Methods: Disability weights studies (1990–2012) in international peer-reviewed journals and grey literature were
identified with main inclusion criteria being that the study assessed DALY disability weights for several conditions or a
specific group of illnesses. Studies were collated by design and methods and evaluation of results.
Results: Twenty-two studies met the inclusion criteria of our review. There is considerable variation in methods used to
derive disability weights, although most studies used a disease-specific description of the health state, a panel that
consisted of medical experts, and nonpreference-based valuation method to assess the values for the majority of the
disability weights. Comparisons of disability weights across 15 specific disease and injury groups showed that the
subdivision of a disease into separate health states (stages) differed markedly across studies. Additionally, weights for
similar health states differed, particularly in the case of mild diseases, for which the disability weight differed by a
factor of two or more.
Conclusions: In terms of comparability of the resulting YLDs, the global use of the same set of disability weights has
advantages, though practical constraints and intercultural differences should be taken into account into such a set.
Keywords: Value of life, Disease burden, Disability adjusted life years, Summary measure of population health,
PrioritisationIntroduction
Human health is threatened by an array of diseases and in-
juries. Limited resources compel policymakers to focus on
threats that are most relevant in terms of public health.
An objective tool that aids policymakers in setting prior-
ities in resource allocation is the disability-adjusted life
year (DALY). The DALY measures the burden of disease,
i.e., it aggregates the total health loss at population level
into a single index by summarizing a) years of life lost due
to premature death (YLLs) and b) years lived with* Correspondence: j.haagsma@erasmusmc.nl
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unless otherwise stated.disability (YLDs) [1]. In this way the DALY estimations
allow comparability between the impact of diseases and
provide knowledge on the size of health problems and the
potential benefit of proposed measures set against similar
and comparable data of other health problems [2,3].
An essential factor for establishing YLDs is the disability
weight, a value assigned to living with disability. This
value, anchored between 0 (perfect health) and 1 (equiva-
lent to death), reflects the impact of a specific health con-
dition. The values of the disability weights are commonly
based on preferences obtained from a panel of judges [4].
Preferences are defined as quantitative expressions or val-
uations for certain health states, which reflect the relativeal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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shown that preferences are dependent on the composition
of the panel, with patients valuing their disease as less un-
favorable compared to the general public [7-9], though
these findings have been disputed [10,11]. Other methodo-
logical aspects that may influence preferences for a certain
health state are the way the health state and duration of
the health state are described and the valuation method
that is used. Each of these aspects affect the preferences
that are measured, which in turn affect the values of the
disability weights [12].
For the ground-breaking Global Burden of Disease
(GBD) 1996 study that estimated the total burden of dis-
ease worldwide a large set of global disability weights
was derived [1,13]. However, because of a need to valid-
ate and improve the novel valuation procedure, a need
for disability weights that reflected preferences of the na-
tional population and/or because of practical limitations
of the GBD 1996 disability weight (i.e., lack of disability
weights for certain diseases or lack of differentiation be-
tween different health states within one disease or dis-
ease group), alternative sets of disability weights have
been developed over the past 16 years, each using differ-
ent approaches with regards to the panel, health state
description, and valuation methods.
This review aims to provide an overview of all studies
that developed disability weights and to compare the
methodological design choices. Four key choices were
addressed: (1) the health state description, (2) time presen-
tation, (3) panel composition, and (4) the valuation method.
Furthermore, disability weights for 15 specific disease and
injury groups resulting from the disability weight studies
were compared with the aim to assess the influence of the
description of the health condition and other design choices
on difference in the disability weights.
Review
Disability weights – design choices
Figure 1 shows a conceptual model of assessing disability
weights and its four main design choices. The first choice
is the health state description. The choices here are to de-
scribe the disease in generic terms or in disease-specific
terms. A disease-specific description depicts the disease
label and/or clinical description; it indicates the causeFigure 1 Conceptual model of assessing disability weights and its deand/or the specific health effects of the condition. A gen-
eric health state description depicts the functional health
independent of the actual underlying condition. For this
purpose a multi-attribute utility instrument (MAUI) is
used [14]. With MAUI, generic attributes are used to clas-
sify health states [7,15,16]. Firstly, patients describe their
health state by choosing a functional level for each attri-
bute. Using weights for the separate attributes, the re-
ported functional level on the attributes is then converted
into a summary score which fits within the 0–1 range,
where 1 is perfect health (the reverse direction compared
to DALY weights). The weights that are used to convert
the health states into a disability weight are derived at an
earlier stage and are based on preference data of the gen-
eral population for health states described with the generic
attributes. This approach is similar to the approach that is
used to derive quality-adjusted life year (QALY) weights,
except that one extra step is taken to transform QALY
weights into disability weights. Widely used MAUIs in-
clude the EQ-5D health questionnaire and Health Utilities
Index (HUI) [17,18]. For the EQ-5D several tariffs exist
for calculating EQ-5D summary scores. Two other ways
to derive health state valuations using the EQ-5D are 1)
to use the visual analog scale (VAS) that accompanies
the EQ-5D and 2) to use the health description system
of the EQ-5D to describe a health state, either with our
without additional disease information, which is then
submitted to a panel of experts or lay people to derive
disability weights [19,20].
The second design choice concerns the time presenta-
tion. The time presentation of the health state can be
distinguished into period profiles and annual health pro-
files. With period profiles, the underlying assumption is
that that the value of the health state is not affected by
the duration of the health state [21,22]. With the annual
profile approach, the course of the health state – the dis-
ability profile – is described over a period of one year
[4,23]. This allows valuation of conditions with an acute
onset, conditions with a short duration, episodic diseases
such as epilepsy, and conditions that are characterized
by complex and heterogeneous recovery patterns. An ex-
ample of an annual profile health state description is a
person who has gastroenteritis for a period of seven days
but for the remainder of the year the person is healthy.sign choices.
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viding the preferences may consist of patients or valid prox-
ies, medical experts, or members of the general public.
The fourth main design choice concerns the valuation
method. To measure individual preferences, several valu-
ation methods exist. These valuation methods include
pairwise comparison, the VAS, time trade-off (TTO), per-
son trade-off (PTO), and standard gamble (SG). Each of
these valuation methods has different properties that
affect the preferences that are measured. The TTO, PTO,
and SG are choice-based valuation methods; asking to
make trade-offs in time (TTO), person-years (PTO), or
risk of death against improvement in health. For a detailed
overview of these valuation methods see [24].
Literature review - selection criteria and definitions
This review is restricted to studies that assessed disability
weights for burden of disease measurements, expressed in
DALY estimates. Empirical studies in the international
peer-reviewed journals and grey literature published in
English in the period 1990 to 2012 were included. Studies
in established market economies and low- and middle-
income countries were all included. This review included
studies that derived disability weights for several groups of
health outcomes or a specific group of illnesses (for in-
stance: periodontal disease or cancer). We excluded
studies that derived a disability weight for one single
health state (because these studies do not give informa-
tion about the relative desirability of a health state com-
pared to other health states), studies that derived
disability weights for risk factors (such as environmental
factors, e.g., noise), and studies that derived severity
weights for QALYs.
Literature review - data sources and search strategy
Searches of eligible studies were conducted in Medline
(PubMed) and EMBASE. All international peer reviewed ar-
ticles published in the period between January 1, 1990 and
December 31, 2012 were included in the searches. Searches
for eligible grey literature were conducted in Google Scholar.
Search terms used for general burden of disease studies
were: “disability weight”, “severity weight”, “burden of dis-
ease”, “disability adjusted life year”, “disability-adjusted life
year”, “DALY”. Keywords were matched to database-specific
indexing terms. In addition to database searches, reference
lists of review studies and articles included in the review
were screened for titles that included key terms.
Literature review - data extraction
Relevant papers were selected by screening the titles
(first step), abstracts (second step), and entire articles
(third step) retrieved through the database searches. Dur-
ing each step, respectively, the title, abstract, or entire art-
icle was screened to ensure that it met the selectioncriteria listed above. This screening was conducted inde-
pendently by two researchers (JH and SP). Disagreement
about eligibility between the reviewers was resolved
through discussion.
Selected full articles were critically appraised by two
reviewers (JH and SP), using data extraction forms,
which included information on the study population, de-
tails regarding the methods used to calculate YLL and
YLD, main conclusions, etc. Their reports were com-
pared and disagreements were resolved by discussion.
Comparison of disability weights
Disability weights of 15 specific diseases/injuries were
compared. We selected 15 diseases/injuries that represent
the complete spectrum of severity (from mild conditions
through very severe conditions) that were included in
more than one disability weight study. Eleven of these
health states were selected from the 22 indicator conditions
of the GBD 1996 study. The four other conditions were se-
lected because one or more of the disability weights studies
focused on this single cause of disease (e.g., periodontal dis-
ease, stroke, or depression).
Results
Figure 2 shows the flow diagram of the search of existing
burden of disease studies and the main reasons for exclu-
sion. In total, 22 disability weights studies were included.
Table 1 presents a detailed overview of the general infor-
mation, health states that were valued, and methodological
design choices of each of the 22 studies. Three studies
were global disability weights studies [25-27] and one
study included a panel of judges from four countries
(United States, South Korea, China, and Taiwan; [28]). All
other studies concerned particular countries or regions.
The majority of the 22 disability weights studies devel-
oped disability weights for a variety of illnesses. Eight stud-
ies concerned disability weights for a specific category (i.e.,
oral/periodontal diseases [34,36], infectious diseases [29],
injuries [20,23,42], urological diseases [38], or stroke [28].
The total number of health states that were valued varied
widely from five [28] to 483 [25].
Methodological design choices to render the disability
weights
Health state description
Five studies (23%) used a MAUI model to assess disabil-
ity weights for health states [23,34,36,42,44]. Four of
these studies used the EQ-5D model or EQ-6D model
(also known as the EQ-5D+model; this model includes an
additional cognitive domain) [23,34,36,42]. One study de-
veloped a new health status classification system, namely
the classification and measurement system of functional
health (CLAMES), which combines selected attributes of
several MAUIs [44].
Figure 2 Flow diagram of the search of existing burden of disease studies.
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based on the Dutch Disability Weights (DDW) study to
derive disability weights for diseases not included in that
study and to adjust annualized estimates for duration for
acute conditions [31].
Eleven studies (50%) depicted the health states in a
disease-specific way [19,20,25-27,30,32,33,35,39,43]. These
disease-specific health state descriptions consisted of short
descriptions or disability scenarios with illustrations or de-
scriptions that included a disease-specific description of
symptoms and generic information. Five studies did not
report how the health states were depicted that were
valued [28-30,37,40].Time presentation
All studies presented the health states as period pro-
files, apart from three Dutch disability weights studies,
which used the annual profile approach [19,20,39]. The
annual profile disability weights for short-term dis-
eases are much lower compared to period profile
disability weights.Panel composition
Of the 17 studies that did not use a MAUI, 59% (n = 10)
asked medical experts or health professionals to value
health states [19,25,28,29,33,35,37,38,40,43]. Three studies
derived preferences from a population panel [20,27,39].Two studies included two panels: medical experts and
people from the population [30,32]. Both studies showed
differences between disability weights derived from these
two groups. Jelsma et al. report a correlation of 0.32 (p =
0.153) between the ranking of health professionals and
people from the population. Baltussen et al. showed that
medical experts valued five of the nine health states sig-
nificantly lower compared to people from the population.
Üstün et al. derived preferences from health professionals,
policymakers, and people with disabilities and their carers
[26] and found that the average correlation of rank orders
between different informant groups was 0.76.
The number of judges varied from nine [28] to
30,230 [27].
Valuation method
Of the non-MAUI studies, nine studies (53%) derived
preferences using a two-step procedure [19,25,29,32,33,
35,37,38,40]. Firstly, preferences for a small subset of
health states were derived using a trade-off method (PTO
or TTO). The second step consisted of an interpolation ex-
ercise, where the panel of judges was asked to interpolate
the remaining health states using the values for the subset.
Other studies used only ranking [26,30], pairwise compari-
son with additional information on population health
equivalence [27], or VAS [43] to derive valuations. In three
studies, all health states were evaluated with a trade-off
method [20,28,39]. Comparison of studies that used more
Table 1 Included studies: Panel of judges, health state description, and time presentation




N panel N health states Health state description Time presentation Valuation methods (% of total
number of health states valued
by each of the methods)
1996 Murray et al. [25] Global M ME 10 483 DS PP <1% PTO, 99% VAS
1997 Stouthard et al. [19] Netherlands M ME 38 175 DS + EQ-5D PP & AP 10% PTO, 90% VAS
1999 Üstün et al. [26] Global M HP, PM, PT, PX 241 17 DS PP 100% ranking
2000 Havelaar et al. [29] Netherlands M ME 35 NA NA PP Interpolation
2000 Jelsma et al. [30] Zimbabwe M PP, ME 68 22 NA PP VAS (ranking)
2000 Mathers et al. [31] Australia M Model - Model MAUI (EQ-6D) + DDW PP EQ-6D: Not applicable
2002 Baltussen et al. [32] Burkina Faso M PP, HP 56 9 DS (scenarios) PP Adapted VAS/interpolation
2003 Schwarzinger et al. [33] Europe M ME, NHP 232 15 DS + EQ-5D PP 100% VAS, 60% TTO, 60% PTO
2004 Brennan et al. [34] Australia S (oral) Model - 18 MAUI (EQ-5D) PP EQ-6D: Not applicable
2005 Kruijshaar et al. [35] Netherlands M ME 49 9 DS + EQ-5D PP 100% interpolation
2007 Brennan et al. [36] Australia S (oral) Model - 6 MAUI (EQ-5D) PP EQ-6D: not applicable
2007 Yoon et al. [37] Korea M ME 30 123 NA PP 13% PTO, 87% interpolation
2008 Basiri et al. [38] Iran S (urologic) ME 10 76 NA PP 100% interpolation
2008 Haagsma et al. [20] Netherlands S (injury) PP 143 44 DS + EQ-5D AP 100% VAS, 100% TTO
2008 Haagsma et al. [39] Netherlands M PP 107 39 DS + EQ-5D AP 100% VAS, 100% PTO
2009 Haagsma et al. [23] Netherlands S (injury) Model - 7 MAUI (EQ-5D) PP EQ-5D: not applicable
2009 Hong et al. [28] US/Southeast Asia S (stroke) ME 9 5 NA NA 100% PTO
2009 Lai et al. [40] Estonia M ME 25 283 DS PP 9% PTO, 91% VAS
2010 Kwong et al. [41] Canada M Model - Model MAUI (CLAMES) PP CLAMES: not applicable
2011 Lyons et al. [42] UK S (injury) Model - 13 MAUI (EQ-5D) PP EQ-5D: not applicable
2012 Salomon et al. [27] Global M PP 30230 220 DS (without label) PP 100% Paired comparison
2011 Van Spijker et al. [43] Netherlands M ME 16 12 DS + EQ-5D PP 100% VAS
NA = not available.
Multiple or single cause of disease: M =multiple, S = single.
Panel: ME =medical experts, HP = health professionals, PM = policymakers, PT = patients/people with disabilities, PX = patient proxies, PP = population.
Health state description: DS = disease-specific, MAUI = generic multi-attribute utility.
EQ-5D =multi-attribute utility instrument that consists of five attributes (mobility, self-care, usual activities, pain/discomfort. and anxiety/depression).
EQ-6D = EQ-5D appended with a cognitive attribute.
Clames model = Classification and Measurement System of Functional Health; a combination of HUI, SF36, and EQ-5D attributes.
Time presentation: PP = period profile, AP = annual profile.
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rankings with VAS were slightly higher compared to agree-
ment of rankings with TTO/PTO [19,20,33,39].Experimental design
Table 2 presents an overview of the experimental design
of the 22 studies. Apart from the GBD 2010 disability
weights study [27], the disability weights were derived
using a written questionnaire. Some studies arranged a
panel meeting with group discussion during which pref-
erences were derived, whereas other studies used indi-
vidual questionnaires. Also, a combination of panel
meetings and individual questionnaires were used.Comparison of disability weights
Comparisons of disability weights for 15 specific disease
and injury groups shows that there is large variation in
disease stages that are used in the studies (Table 3). For
instance, the number of health states of CVA/stroke
ranges from one [40] to five [27,28]. Also, there is large
variation between studies in the values of the disability
weights for similar health states. For instance, the dis-
ability weight for paraplegia ranges from 0.047 (treated
paraplegia) and 0.440 (untreated paraplegia) [27] to
0.725 [25], and the disability weight for severe depres-
sion ranges from 0.147 [40] to 0.83 [19]. Particularly in
the case of mild health states, the disability weight can
differ by a factor of two or more. The disability weight
for cystitis ranges from 0.01 [19] to 0.023 [41]. For se-
vere gastroenteritis, the disability weights (period profile)
range from 0.061 [27] to 0.393 [29].
For four studies, we have tabulated the rankings of 12
diseases and calculated the rank order correlation (Ʈ) for
each of the sets of disability weights. The results shown
in Table 4 reveal that there is consistency in the rankings
between the GBD 1996, the DDW, and the Estonian dis-
ability weights study, with Ʈ ranging between 0.426 (p <
0.05) and 0.626 (p < 0.01). However, the rank order cor-









Panel meeting + questionnaire 3 [19,20,39]
Questionnaire + panel meeting 1 [32]
Questionnaire + panel meeting +
questionnaire
1 [28]
Interview 2 [26,27]the GBD 2010 study and the other three disability
weights studies included in the comparison.
It seems that studies that used ranking and VAS and
studies that provided a short disease-specific health state
description resulted in slightly worse disability weights
compared to studies that presented generic information
on functional health in addition to the disease-specific
information (Table 3). However, the actual descriptions
of each of the selected conditions were not available.
Therefore, it was not possible to perform a detailed ana-
lysis to assess whether the differences are related to the
presentation of the health state and/or other methodo-
logical design choices.
Discussion
Twenty-two disability weights studies were included in the
review. The total number of health states valued in these
studies varied from five to more than 400. The results of
this systematic review showed that there is variation in
methods used to derive disability weights. However, most
studies used a disease-specific description of the health
state, a panel that consisted of medical experts, and a
nonpreference-based valuation method to assess the values
for the majority of the disability weights. Comparisons of
disability weights across 15 specific disease and injury
groups showed that the subdivision of a disease into separ-
ate health states (stages) differed markedly. Additionally,
weights for similar health states differed, particularly in the
case of mild diseases, for which the disability weight dif-
fered by a factor of two or more.
Coverage of diseases and disease staging
As mentioned above, we found marked differences in
coverage of diseases and subdivision of a disease or in-
jury into different health states. The GBD 1996 and the
Estonian disability weights sets cover a wider range of
conditions than the Dutch disability weights, but are
generally less specific in terms of the specific disease
stages to which they refer. The set of Dutch disability
weights covers a restricted range of conditions compared
to the GBD disability weights, but it provides more de-
tailed differentiation between disease stages and sever-
ities, thus allowing more detailed disease models in
estimating the YLDs than is possible with the GBD or
Estonian disability weights [40].
Disability weights studies that focused on a single
cause of disease (e.g., periodontal disease, stroke, or de-
pression) also included more detailed disease stages.
Often these studies were conducted because the disabil-
ity weights that are available from the GBD 1996 set are
not tailored to the available data on incidence or preva-
lence. If, for example, the impact of the disease among
incident cases is markedly better or worse than that rep-
resented by the available “disability weights”, data on
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Table 3 Disability weight of eight diseases/injuries (Continued)
[20] Haagsma
et al., 2008
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severe 0.086
0.023
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et al., 2000
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[30] Jelsma et al.,
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[31,47] Mathers et al.,
2000
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[32] Baltussen
et al., 2002
- - - PP: 0.16; HP: 0.11 - - PP 0.35; HP 0.36
[33] Schwarzinger
et al., 2003
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[35] Kruijshaar
et al., 2005
- - - - - - -
[36] Brennan
et al., 2007
- - - - - - -
[37] Yoon et al.,
2007
NA NA NA NA NA NA NA
[38] Basiri et al.,
2008
- - - - - - -
[20] Haagsma
et al., 2008
- - - - - - -
[39] Haagsma
et al., 2008
- - - - - - -
[23] Haagsma
et al., 2009
- - - - - - -
[28] Hong et al.,
2010
- - - - - - -
[40] Lai et al.,
2009
0.168 0.547 0.747 0.254 0.242 0.261 0.478
[41,44] Kwong et al.,
2010





















Table 3 Disability weight of eight diseases/injuries (Continued)
[42] Lyons et al.,
2011
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Murray et al., 1996 X 0.462* 0.626** 0.351
Stouthard et al., 1997 X 0.534* 0.107
Lai et al., 2009 X 0.515*
Salomon et al., 2013 X
**p < 0.01; *p < 0.05.
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the functional outcomes of that disease. In addition, dis-
ability weights for certain health outcomes may not be
available or appropriate, e.g., for infectious diseases
(Guillain-Barré syndrome, irritable bowel syndrome, re-
active arthritis) [39], injuries (concussion) [20], or peri-
odontal disease [34,36].Panel composition and contextual differences
Using disability weights based on societal preferences
has been recommended, because burden of disease stud-
ies are primarily used as a tool for guiding decision-
making on resource allocation at the population level
[3]. Nonetheless, the majority of studies asked medical
experts or health professionals to value health states.
Three studies asked both medical experts and members
of the general public [26,30,32]. The results of two of
these studies showed significant differences between dis-
ability weights derived from these two groups. Also, it
should be noted that diseases and injuries rated as less
severe by experts in a high-income country might be
rated as more burdensome by people in health care in
low-income settings. Two studies compared health state
valuations among residents of several countries. A study
among European countries showed that ranking of
health states is similar across countries [33]. However,
Üstün et al. found that for the majority of health condi-
tions there were significant differences in ranking be-
tween 14 countries. Salomon et al., on the other hand,
reported a high degree of consistency between sites, with
the exception of one site [27]. Previous studies have
shown that there are clear contextual differences in the
ways people perceive health problems and how such
problems affect their lives [48-52]. The findings from
Jelsma et al. suggest that contextual differences may be
stronger among lay people compared to health profes-
sionals [30]. Further research is needed to gain greater
insight into the effect of contextual differences on dis-
ability weights.Health state description
Five studies used a MAUI model (e.g., EQ-5D or CLAMES)
to assess disability weights. A MAUI model describes thehealth state with generic attributes only, whereas disease-
specific health state descriptions may include disability
scenarios with illustrations, a specific description of the
symptoms, and/or information on treatment. Disease-
specific health state descriptions have been shown to be
more sensitive for the detection and quantification of
small changes [53], see e.g. Stouthard et al. [46] who com-
bined disease-specific information with EQ-5D data [46].
They found that low back pain and prostate cancer, health
states with a similar EQ-5D profile but a different disease
label, yielded different values. This indicates that disease-
specific health state descriptions provide information that
is not reflected in the generic health states but which mat-
ters for health state valuation. Which information is
reflected in the generic health state, however, depends on
the MAUI that is used, as they differ in the number and
type of health domains that are included, the total number
of possible health states, and the health state valuation
techniques that are used to assess the weights that are
assigned to the health domains. When an extensive
disease-specific description of a health state is used, it is
important to realize that the description may produce in-
formation bias because of message-framing effects [54].
Empirical studies have shown that the manner of depicting
the health state affects preferences for these health states
[55]. Secondly, including information on the symptoms of
the disease, the impact on daily functioning, and duration
in the description of the health state may result in cogni-
tive overload of the panel of judges, especially if the panel
of judges consists of members of the general public.
We recommend using a combination of a generic and
disease-specific health state, because it has been shown
that even for expert panels, adding a generic description
of functional health status to the diagnostic disease label
is necessary to standardize the stimulus [33,46,56]. Fur-
thermore, utilizing an unadjusted MAUI model, such as
the EQ-5D, to assess disability weights may be inconsist-
ent with the objective of DALYs, because disability weights
in GBD and other population-based burden of disease
studies are adjusted to ascertain that the burden of disease
from all causes adds up to the total burden of disease in
the population. The unadjusted MAUI-based disability
weights do not have such a restriction.
Time presentation: period versus annual profiles
Disability weights can be subdivided into period profile
and annual profile disability weights. Period profile dis-
ability weights assume independence between duration
and disability and they require that the health state re-
mains constant over time. This assumption is untenable
for disorders that are characterized by a complex time-
severity course [57], because it is impossible to disaggre-
gate complex time patterns into a limited number of
homogeneous stages. A solution proposed to overcome
Haagsma et al. Population Health Metrics 2014, 12:20 Page 12 of 14
http://www.pophealthmetrics.com/content/12/1/20this problem was the annual profile approach, which de-
scribes the health profile over a period of one year [4].
The results of this systematic review showed that the an-
nual profile approach has not been adopted internation-
ally. This may be due to several reasons. Firstly, it has
been argued that the annual profile approach may over-
value diseases with a mild and rapid course [58], though
this may be corrected by using a relevance criterion for
the inclusion of incident or prevalent cases [39]. A sec-
ond, more practical, reason may be that the annual pro-
file disability weights are rather inflexible with regard to
time. If health states with different durations than the
duration included in the annual profile are needed, they
cannot be derived by back-calculation. Thus, the initial
disability weights have to be applied, even though the
duration does not match, or a new annual profile disabil-
ity weight has to be derived with a new panel study.
Valuation methods
A majority of disability weight studies used ranking,
interpolation, paired comparison, or the VAS to assess the
values for disability weights. These valuation methods lack
the trade-off feature; they do not ask to sacrifice some-
thing valuable in order to assess the undesirability of the
health state. Therefore, in a technical sense, these studies
do not assess preferences but values [14]. The values elic-
ited with VAS, and to a lesser degree with paired compari-
son, ranking, and interpolation, give information about
the relative desirability of a health state compared to other
health states (A is valued higher than B in a VAS, therefore
A is preferred to B), but it is impossible to reasonably infer
the trade-offs that people are willing to make [6]. Regard-
ing the actual values of the disability weights, many studies
have found that health state valuations with the VAS tend
to be higher compared to equivalent valuations with
choice-based valuation methods [20,59,60]. The results
from this study appear to support those findings.
Validity
In the absence of a gold standard for the disability com-
ponent it is difficult to evaluate the validity of disability
weights. One way to study the validity of disability weights
is by tabulating and comparing the rankings of matching
diseases and injuries of several studies. These comparisons
showed a high degree of consistency in ranking between
the GBD 1996 study, DDW, the Estonian disability
weights study, and the GBD 2010 study. However, it
should be noted that to calculate a disability weight for the
12 matching diseases and injuries we needed to aggregate
disability weights for different disease stages of several
studies very crudely. A second approach to assess validity
is to compare the disability weights of disease stages
within a certain disease or injury. Many studies subdivided
a disease or injury into disease stages and comparison ofthe disability weights of these disease stages showed that
the more severe health states have a higher disability
weight compared to less severe health states, indicating
high face validity.
Comparison of disability weights
A major finding of this study is the fact that the values of
the disability weights across studies differ markedly. As a
result, disability weights from studies with different designs
cannot be used interchangeably. This raises the question of
whether DALY estimates from studies using different sets
of disability weights can be compared to each other, since a
disability weight that is twice as high might result in a YLD
that is twice as high if the same duration and incidence or
prevalence numbers are applied. The GBD 2010 study
showed major shifts in rankings of causes of burden of dis-
ease, and these differences can, to some extent, be traced
back to marked differences in disability weights (e.g., back
pain and sensory disability) [61]. Hence, to meet the pur-
pose of the DALY, namely to assess the burden of disease
and injury at the population level for comparability of im-
pacts of different diseases and risk factors over time and
between regions, it is important to use the same set of uni-
versal disability weights.
Conclusions
Methodological constraints, contextual differences, and
practical limitations have urged burden of disease re-
searchers to derive alternative sets of disability weights,
each using a different approach with regard to the panel,
health state description, and valuation methods, result-
ing in widely varying values for similar health states.
However, in terms of comparability of the resulting
YLDs, the global use of the same set of disability weights
is preferable.
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